MP61-17 CELL-FREE DNA AS A PROGNOSTIC MARKER FOR RESPONSE TO TAXAN-BASED CHEMOTHERAPY IN PROSTATE CANCER (CAP) PATIENTS

Authors :: David G. Pfister
Daniel Porres
Axel Heidenreich
Timur H. Kuru
Alexandra Kienel
Source :: Journal of Urology. 193
Publication Year :: 2015
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2015.

Subjects :: Oncology
PCA3
medicine.medical_specialty
Chemotherapy
business.industry
Urology
medicine.medical_treatment
medicine.disease
Prostate cancer
Cell-free fetal DNA
Internal medicine
medicine
Cancer research
business

Tools